ECRIN's Norvegian national partner, Norwegian Clinical Research Infrastructure (NorCRIN), shares some of its latest news below.
1. NorCRIN applied to Norwegian Research Council funding (50 million kroner) to finance NorCRIN-partners' work and ECRIN membership (5 more years after 2020). The response is anticipated in June 2019.
2. NorCRIN did a user survey in September 2018. A total of 149 users answered the survey.
Initial analysis reveals the following: 75% of users have been involved in academic studies and 46% in industrial studies. The users know NorCRIN from its website (51%); participation in GCP courses (44%); and participation in studies (41%). We asked how satisfied users were with NorCRIN's services and 72.3% answered that they were satisfied or very satisfied, while 23.4% were neutral and 4.3% were unhappy. 77% said they would use NorCRIN again (only 5% said they would not).
3. NorCRIN is in the process of planning a new user seminar on 25 September 2019. Users are defined as researchers, individuals/institutions providing support for research, and small and medium-sized companies within the pharmaceutical industry / medical technology. Several speakers will be invited.